| Date Filed | Type | Description |
| 08/23/2023 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,600 shares
@ $107.3975, valued at
$171.8k
|
|
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/11/2023 |
4/A
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC |
| 05/11/2023 |
4/A
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC |
| 02/08/2023 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,280 shares
@ $105.6256, valued at
$135.2k
Sold 2,030 shares
@ $102.2872, valued at
$207.6k
Sold 15,360 shares
@ $102.4235, valued at
$1.6M
Sold 980 shares
@ $104.1184, valued at
$102k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 400 shares
@ $125, valued at
$50k
Exercised 400 options to buy
@ $43.24, valued at
$17.3k
|
|
| 12/01/2022 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 22,162 shares
@ $125.9017, valued at
$2.8M
Sold 7,775 shares
@ $125.9017, valued at
$978.9k
Sold 20,063 shares
@ $125.9017, valued at
$2.5M
Exercised 22,162 options to buy
@ $41.78, valued at
$925.9k
Exercised 7,775 options to buy
@ $35.99, valued at
$279.8k
Exercised 20,063 options to buy
@ $43.24, valued at
$867.5k
|
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 809 shares
@ $80.6787, valued at
$65.3k
Sold 2,030 shares
@ $80.828, valued at
$164.1k
Sold 1,280 shares
@ $80.78, valued at
$103.4k
Sold 980 shares
@ $79.6659, valued at
$78.1k
|
|
| 02/02/2022 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 62,483 options
@ $79.02, valued at
$4.9M
Granted 9,175 restricted stock units
@ $0 |
|
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 3,477 shares
@ $120.0251, valued at
$417.3k
Sold 1,600 shares
@ $120.0275, valued at
$192k
Sold 300 shares
@ $120, valued at
$36k
Sold 100 shares
@ $120, valued at
$12k
Exercised 3,477 options to buy
@ $41.78, valued at
$145.3k
Exercised 300 options to buy
@ $41.78, valued at
$12.5k
|
|
| 11/16/2020 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,257 shares
@ $90.7058, valued at
$204.7k
|
|
| 11/04/2020 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 20,595 shares
@ $96.5269, valued at
$2M
Exercised 20,595 options to buy
@ $35.99, valued at
$741.2k
|
|
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2020 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,934 shares
@ $99.4508, valued at
$192.3k
|
|
| 04/17/2020 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 8,632 shares
@ $94.6499, valued at
$817k
|
|
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,145 shares
@ $103.1121, valued at
$118.1k
Sold 809 shares
@ $102.9022, valued at
$83.2k
Sold 1,395 shares
@ $101.4773, valued at
$141.6k
Granted 61,347 options
@ $102.9, valued at
$6.3M
Granted 9,719 restricted stock units
@ $0 |
|
| 07/17/2019 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 5,835 shares
@ $87.4381, valued at
$510.2k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2018 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 12,350 shares
@ $97.3412, valued at
$1.2M
|
|
| 02/07/2018 |
4
| BENEVICH ERIC (Chief Commercial Officer) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 820 shares
@ $83.1393, valued at
$68.2k
Paid exercise price by delivering 917 shares
@ $82.48, valued at
$75.6k
Granted 34,750 options
@ $81.49, valued at
$2.8M
Granted 6,150 restricted stock units
@ $0
Granted 12,250 restricted stock units
@ $0 |
|
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |